IL6 and metabolic dysfunction-associated steatotic liver disease: Hence, the exacerbated systemic inflammation characterized by elevated circulating levels of cytokines and activation of pro-inflammatory signaling pathways during the NAFLD progression can be clearly evidenced from our results showing the progressive increase of IL-6 and thus can be used as a reliable plasma cytokine marker.